Displacement-loops (D-loops) are pivotal intermediates of homologous recombination (HR), a 2 universal DNA double strand break (DSB) repair pathway. We developed a versatile assay for 3 the physical detection of D-loops in vivo, which enabled studying the kinetics of their formation 4 and defining the network of D-loop formation and reversal pathways. Nascent D-loops are 5 detected within 2 hrs of DSB formation and extended over the next 2 hrs in a system allowing 6 break-induced replication. The majority of D-loops are disrupted in wild type cells by two 7 pathways: one supported by the Srs2 helicase and the other by the Mph1 helicase and the Sgs1-8 in HR and is forming an extended D-loop. DNA synthesis restores the sequence information 1 disrupted by the DSB. While disruption of nascent D-loops is a mechanism of anti-2 recombination, disruption of extended D-loops represent a mechanism of crossover avoidance 3 et al., 2015). dHJ dissolution requires both the Sgs1 helicase and Top3 topoisomerase activity.
design purposedly restrict joint molecules to nascent and extended D-loops (Fig. 1B) . The DSB- . S1) , and is referred to as the DLC signal. 6 As expected, the DLC signal depends on DSB formation (Fig. 1C) , homology between the 7 broken and donor molecules (Fig. 1D) , and the central HR proteins required for filament 8 assembly (Rad52) (Zelensky et al., 2014) and DNA strand invasion (Rad51 and Rad54) 9 (Petukhova et al., 1998) ( Fig. 1E) . Contrary to previous proxy assays for DNA strand invasion Wright and Heyer, 2014). Together with the reliance of DLC on homology, D-loop stabilization 13 by psoralen crosslinking and restoration of the restriction site eliminated by resection ( Fig. 1F) , 14 these results demonstrate that the DLC assay detects D-loops and not nonspecific contacts 15 between the broken and the donor molecule.
16
Limitations of the DLC assay 17 A first limitation of the DLC assay resides in the psoralen-mediated inter-strand crosslink density 18 (≈1/500 bp) (Oh et al., 2009). Since the in vivo hDNA length distribution is unknown, the DLC 19 assay cannot distinguish between a single long and several shorter D-loops comprising the same 20 total length of hDNA ( Fig. S2A) . Consequently, a change in DLC can reflect either an increase 21 of the average hDNA length or an increase of the amount of D-loops in the cell population. 22 Second, upon long-range DNA synthesis, the D-loop will move away from the homologous 23 donor loci and thus from the upstream restriction site. If it migrates past a downstream EcoRI 24 site (located 11.1 kb away in our design), it will cause a physical uncoupling between the hDNA 25 (i.e. the crosslink point between invading and donor molecules) and the upstream restriction site 26 used for DLC chimera formation, thus precluding proximity ligation of both partners (Fig. S2B) . 27 In this study, we focus mainly on nascent D-loops, i.e. before extension by DNA polymerase, 28 avoiding this potential limitation. White and Haber, 1990 ). D-loop formation is first detected 1 hr after DSB induction 4 and increases 40-fold over 3-4 hr when it peaks before declining slightly ( Fig. 2A) . D-loop 5 extension (monitored with another recently developed assay (Piazza et al., 2018); Fig. S3 ) 6 follows with a ≈2 hrs delay: first detected at 4 hr, it peaks at 6 hr and plateaus ( Fig. 2A) . The 7 mean time between half the DSB are formed (≈20 min) and half the maximum DLC and DLE 8 signals are reached is DLC50 = 122 ± 13 min and DLE50 = 278 ± 23 min, respectively ( Fig.   9 2B). This delay enables the separate study of nascent and extended D-loops at 2 and 6 hr post- 10 DSB induction, respectively. 12 We addressed the role of the Mph1 and Srs2 helicases as well as the helicase-topoisomerase STR 13 complex in nascent and extended D-loop metabolism. Deletion of either MPH1 or SRS2 results 14 in a significant 2-3 fold DLC increase at all time points ( Figs. 3A and 3C , respectively). The 15 decrease observed between 2 and 4-6 hours in the srs2∆ mutant, from 2.9 to 1.8-fold over WT 16 levels, is not statistically significant (Fig. 3C) . The ATPase-deficient mph1-D209N and srs2- 17 K41A mutants also exhibit elevated DLC levels compared to wild type, not significantly different 
11

Role of Srs2, Mph1 and STR in the dynamics of nascent and extended D-loops
23
In contrast, STR significantly inhibits DLC only at the earliest time point: a sgs1∆ mutant 24 exhibits a significant 2-fold DLC increase at 2 hrs post-DSB induction but not at 4 and 6 hrs 25 ( Fig. 3E) . Unlike Mph1 and Srs2, DLC in the ATPase-deficient sgs1-K706A mutant is 26 significantly lower than in the deletion mutant and not significantly different from wild type 27 ( Fig. 3F) , indicating that the STR inhibitory effect requires the physical presence of Sgs1 but is 28 largely independent of its helicase activity. Previous genetic observations showed that a subset of 29 STR roles requires the physical presence of Sgs1 and its ability to interact with Top3, but is 3G). However, overexpression of top3-cd leads to a ≈2.5-fold DLC increase over the empty 10 vector control ( Fig. 3G) , an increase similar to that observed in a sgs1∆ mutant. TOP3 and SGS1 11 are epistatic, as neither TOP3 not top3-cd overexpression affects DLC levels in a sgs1∆ mutant 12 ( Fig. 3G) . Overexpression of top3-cd in sgs1-K706A cells yields an intermediate, although non-13 significant, effect compared to either wild type or sgs1∆ cells ( Fig. 3G) . This intermediate effect 14 may suggest a subtle contribution of Sgs1 helicase activity to STR-mediated D-loop disruption. 15 These results show that nascent D-loop disruption requires the topoisomerase activity of Top3- 
21
In conclusion, these results provide direct evidence for three D-loop disruption activities in yeast.
22
STR disrupts nascent D-loops in a topoisomerase-dependent and mostly helicase-independent 23 fashion. Srs2 and Mph1 disrupt both nascent and extended D-loops in a helicase-dependent 24 fashion. 26 We next investigated the genetic interactions between these D-loop disruption activities, 27 focusing on nascent D-loop regulation. Cells defective for both Mph1 and STR do not exhibit 28 additional DLC increase: the DLC profile in the mph1∆ sgs1∆ double mutant resembles that of a 29 sgs1∆ single mutant at all time points ( Fig. 4A) . Furthermore, top3-cd overexpression in the 30 absence of Mph1 does not yield further nascent DLC increase ( Fig. S4A) . This epistatic 1 relationship is independent of the helicase activity of STR ( Fig. 4B) . These results indicate that 2 STR and Mph1 operate in the same nascent D-loop disruption pathway. Regulation of extended 3 D-loops is more complex, as the increased DLC observed at 6 hr in the mph1∆ mutant depends 4 on STR ( Fig. 4A) , suggesting an antagonistic role in this context. We next addressed the genetic interactions of SRS2 with STR and MPH1 on nascent D-loop 8 metabolism. First, overexpression of top3-cd in a srs2∆ mutant causes a significant 1.9-fold DLC 9 increase over the empty vector control ( Fig. 5A ), suggesting that Srs2 operates in a different D- degradation also leads to a significant DLC increase in the sgs1∆ and mph1∆ mutant background 17 ( Fig. 5D) . Importantly, the absolute DLC increase observed upon Srs2 depletion in these mutants 18 is not significantly different from what is seen in a wild type strain ( Fig. 5E) , indicating that the 19 defect imparted by the absence of Srs2 is additive to that of the other mutations. The absence of 20 epistasis or synergy but apparent additivity between the Srs2 and the STR-Mph1 disruption 21 pathways indicate (i) that they target different nascent D-loop substrates, and (ii) that these 22 substrates do not interconvert.
25
STR and Mph1 are part of the same nascent D-loop disruption pathway
23
Rdh54 inhibits nascent D-loops in an ATPase-independent fashion as part of the STR-
24
Mph1 pathway 25 We sought to determine the apical determinant(s) of these two nascent D-loop disruption 26 pathways. We surmised that it should involve components of the DNA strand invasion apparatus. 
12
Deletion of RDH54 causes a strong (≈3-fold) DLC increase at early time points corresponding to 13 nascent D-loops ( Fig. 6A) . Intriguingly, the ATPase-defective rdh54-K318R mutant did not 14 cause DLC increase, indicating that the early inhibitory effect of Rdh54 is exerted independent 15 of its catalytic activity ( Fig. 6B) . RDH54 is epistatic to SGS1 and MPH1, as any mutant 16 combination exhibits a similar ≈3-fold DLC increase over wild type (Fig. 6C) . This result was 17 corroborated upon top3-cd overexpression in rdh54∆ and rdh54∆ sgs1∆ cells, which did not 18 exhibit significant increase over the empty vector control ( Fig. S6A) . Consequently, Rdh54 Remarkably, the rdh54∆ srs2∆ mutant exhibits a strong nascent DLC increase, 12-fold 25 over wild type levels ( Fig. 6D) . This increase is 4-fold higher than any single mutant, indicating 26 that SRS2 and RDH54 synergistically inhibit nascent D-loop. Hence, Rdh54 is epistatic to the 27 STR-Mph1 disruption axis but exhibits unique genetic interactions with the Srs2 pathway, both 28 for DLC (synergy) and viability (no synthetic lethality). No synergy is observed in the rdh54-29 K318R srs2∆ mutant ( Fig. 6E) , confirming that the catalytic activity of Rdh54 is not required for 30 its role in DLC inhibition. Based on these results, we propose that Rdh54 demarcates the two 1 nascent D-loop disruption pathways (see below and Figure 7 ). 2 
Discussion
3
The DLC assay: a versatile tool for studying DNA strand invasion in cells 4 The DLC assay enables physical detection in cells of D-loops, a central yet elusive intermediate 5 of the HR pathway. More generally, this assay can detect any association between DNA 6 molecules mediated by a regional hDNA crosslinkable with psoralen. The simple rationale 7 related to 3C-type approaches and the large dynamic range (spanning over three orders of 8 magnitude) of the qPCR readout grants applicability to experimental systems with less frequent 9 DSB formation and/or DNA strand invasion than in our system. For example, we previously 10 used a variant of this assay to detect the multi-invasion HR byproduct (Piazza et al., 2017). Since 11 psoralen has already been extensively used in a variety of organisms (including mammalian 12 cells) and DSB delivery by CRISPR-Cas9 is nearly universally applicable, we expect this 13 versatile approach to open the way for physical study of the HR process in various organisms 14 and cell types.
15
Nascent D-loop dynamics: implications for HR fidelity and outcome 16
The steady-state DLC increase observed in various mutants reveals that the majority of D-loops 17 formed at a perfectly homologous 2 kb-long donor are normally being disrupted in wild type 18 cells. We provide direct evidence for three activities underlying this nascent and/or extended D- While extended D-loop disruption is integral to the SDSA pathway, the role of disruption 26 activities targeting perfectly homologous nascent D-loop is less straightforward within the 27 current HR framework, but we speculate it participates in HR fidelity in three main ways. First, 28 we showed previously that these activities inhibit multi-invasion-induced rearrangements, a ). Hence, a blind sampling engine that has no knowledge whether it has reached the best 7 genomic target is afforded a "second chance". Given that homology length stimulate and that Genetic interaction between these regulatory activities also revealed unexpected complexities in 24 nascent D-loop metabolism ( Figs. 4 and 5) . Indeed, STR with Mph1 and Srs2 define two 25 independent nascent D-loop disruption pathways ( Fig. 7) . Importantly, combined elimination of We propose a model for nascent D-loop metabolism by STR-Mph1 and Srs2 in which Rdh54 3 acts as a gate keeper in delineating the two disruption pathways (Fig. 7) . Rdh54 promotes the other pathway, remains to be addressed (Fig. S6B) . Indeed, DNA strand invasion can occur not 20 only at the 3'-OH extremity but also internally, although slightly less efficiently (Adzuma, 1992; 
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